What do you actually know about Melanotan II dosing before you trust a number someone posted online? Reviewing products for a living has left me suspicious of any figure that sounds confident but has nothing solid behind it. So when I started digging into dosing protocols for this compound, braced for the usual forum bravado, one fact stopped me cold before my coffee was even finished. The number of regulator-approved cosmetic dosing protocols for Melanotan II, anywhere on Earth, is zero. Not limited. Not still being studied. Zero.
Everything else you’ll read about “starting doses” and “loading phases” traces back to either small early research or people typing with confidence on a forum at 2am. As a reviewer, that’s the moment you stop taking the marketing copy at face value and start grading on the evidence you can actually verify.
The hype
Here’s the pitch, as it’s usually sold: start low, load up over a couple of weeks with small daily microgram injections, then taper to a maintenance shot twice a week, and you’ll have a tan without the sunburn. It reads like a protocol. It has the cadence of instructions. Someone, somewhere, clearly believes this is settled science.
It is not. It’s user convention dressed up as a regimen, and no clinical trial has ever tested that loading-then-maintenance schedule for either safety or results. That’s not me being cranky about internet advice. That’s the actual state of the literature.
The honest grade
I like a scorecard, so here’s the one this topic deserves, translated from the underlying research into something closer to a report card:
| Dosing claim | The pitch | My grade | The receipts |
|---|---|---|---|
| Melanotan II tans skin at microgram doses | Small subcutaneous doses visibly darken skin | Moderate (human) | Shown in small early studies (Dorr 1996; Dorr 2004) |
| Higher doses cause more nausea | Side effects scale with dose | Strong (human) | Directly reported, dose-dependent severe nausea (Wessells 2000) |
| A “loading then maintenance” schedule is optimal | Daily low doses, then taper to hold the tan | Very low | Never trialed; pure user convention |
| A precise “safe” microgram number exists | e.g. one specific daily dose that’s fine for healthy adults | None | No approved dose, no long-term safety trial |
| The vial contains what the label says | Labeled dose equals delivered dose | None (gray market) | No identity or purity guarantee on an unregulated product |
Two claims pass. Two things, total: it can tan you, and more of it makes you sicker. Everything that sounds like an actual regimen, the tidy phases, the specific numbers people quote like they’re reading off a prescription bottle, scores at the bottom. That gap between what sounds authoritative and what’s actually been tested is, frankly, the whole review in one table.
Where the two passing grades actually come from
Credit where it’s due. Two early human studies do real work here. A 1996 pilot phase-I trial gave Melanotan II to healthy volunteers at low subcutaneous doses and documented visible tanning, along with the honest cost of it: nausea and facial flushing showed up as the most common complaints (Dorr et al., 1996, Life Sciences). A later study paired a compound from the same class with actual UV exposure and again confirmed the skin darkened (Dorr et al., 2004, Archives of Dermatology).
Then there’s the study that, to me, is the single most useful data point in this entire review, and it’s a warning label, not a target number. In a placebo-controlled trial, Melanotan II produced erections in 17 of 20 men, and researchers reported frequent nausea and yawning, with severe nausea showing up more at higher doses (Wessells et al., 2000, International Journal of Impotence Research). Notice what that number actually tells you. Not a milligram figure to aim for, but a direction: push the dose, push the nausea. That’s the most solid dose-response fact anyone has on this compound, and it’s a fact about getting sicker, not a fact about optimizing anything.
And let’s be honest about sample sizes, because a reviewer who ignores this isn’t doing their job. Twenty men can show you an effect exists. Twenty men cannot tell you how often a rare, serious harm shows up, because rare things don’t reliably appear in a room of twenty people. So even the “moderate” and “strong” grades above are built on small studies. Small numbers are a shaky foundation for anyone’s confidence about long-term safety, no matter how often those numbers get repeated as fact.
The reviews that don’t count (because nobody’s checking the product)
Here’s my problem with forum dosing advice, framed the way I’d frame a suspiciously five-star product page: the reviews sound specific, but nobody verified what they actually bought.
Someone posts that they took “500 micrograms” and tanned beautifully. Fine. Except research-chemical vials carry no guarantee of identity, purity, or actual peptide content, a hazard a 2017 review named directly, warning about injecting an unlicensed product of unknown quality (Habbema et al., 2017, International Journal of Dermatology). So that “500 micrograms” is really 500 micrograms of whatever happened to be in an unverified vial. Could be more. Could be less. Could be something else with a similar name on a similar-looking label.
Then stack the reconstitution math on top, because it only gets messier. Someone dissolves a lyophilized powder of unverified actual mass in a self-measured volume of bacteriostatic water, then draws a fraction of that up by eye in an insulin syringe. Every one of those steps has its own margin of error, and errors compound. A “250 microgram” dose measured this way could plausibly be off by a wide margin before you even get to the uncertainty baked into the original vial. Those precise-sounding numbers people trade like trusted product specs are, in reality, estimates stacked on estimates. Treating that as an exact figure is the reviewer’s equivalent of trusting a product photo that’s obviously been retouched.
The one variable every “protocol” conveniently skips
Here’s what almost never makes it into these forum write-ups: your skin type. Dermatologists use the Fitzpatrick scale, running roughly from type I (fair skin that burns and doesn’t tan) through type VI (deeply pigmented skin). This matters enormously, because the people most drawn to a tanning peptide tend to be exactly the fair-skinned types who tan poorly in the first place, and those are the same people at higher baseline risk for the skin-cancer concern this literature flags.
The copy-paste “loading phase” protocols are written as though one microgram schedule fits every body. It doesn’t. Someone with fair skin and a lot of moles is in a fundamentally different risk category than someone with darker skin and few moles, and no forum thread accounts for that difference. A dosing plan that doesn’t ask who’s taking it isn’t really a dosing plan. It’s a guess with a font.
The harm you can’t dose around
Some reviews come down to “the product just isn’t for you, no matter how you use it,” and that’s basically the case-report literature here.
A young woman with fair skin developed melanoma after a course of self-injections meant to deepen a sunbed tan, prompting the authors to urge clinicians to counsel at-risk patients about the drug (Hjuler and Lorentzen, 2014, Dermatology). Men have shown up with priapism, a painful, prolonged erection that’s a genuine urological emergency capable of causing permanent damage (Dreyer et al., 2019, BMJ Case Reports).
Neither of those is a dosing problem with a clever fix. The melanoma concern is tied to stimulating pigment cells in the first place, and priapism comes from the same melanocortin activity that produces the effect people are chasing. You cannot dial your way around a mechanism. A smaller number might mean less nausea. It does not mean less risk of the things that actually put people in an emergency room or a dermatologist’s chair.
What actually earns trust here
If nothing in this compound’s dosing story has earned a passing grade, what would actually move the needle for me as a reviewer? Two things, and neither of them is a magic microgram figure.
First, a verified product, meaning a licensed pharmacy stands behind what’s actually in the vial, instead of an anonymous seller shipping powder of unknown origin. Second, an actual person watching for the specific warning signs this literature keeps pointing at: a changing mole, blood pressure that’s drifting, side effects that are escalating rather than settling.
FormBlends is one entity that treats Melanotan II this way, inside an actual clinical relationship where a physician reviews someone’s history first and a licensed pharmacy handles what gets dispensed, rather than a stranger’s PayPal link. It also offers a tracker app so people can log doses and watch their own response over time, which at minimum converts the experience into something a clinician can review, instead of a vague memory of “I think I felt worse on Tuesday.”
I want to be precise about what that does and doesn’t earn. A logged dose is not a safe dose. Supervision doesn’t turn an unapproved compound into an approved one. Compounded medications are prepared by licensed pharmacies for an individual and are not FDA-approved products, full stop. What a tracker and a clinician’s oversight actually deliver is the one thing gray-market dosing structurally cannot: a real record and a licensed set of eyes watching for the harms this article just walked through, instead of a stranger’s forum post and a hope.
The verdict
Strip away everything that sounds like a protocol but isn’t, and you’re left with two honest facts: small doses can tan you, and bigger doses make you sicker. That’s it. That’s the reviewable content. The loading phases, the maintenance schedules, the precise-sounding microgram targets, none of it has been tested, and none of it can even be verified against what’s actually in the vial you bought. The serious harms in the case reports don’t scale down with a smaller dose, because they’re tied to what the compound does, not how much of it you take.
If you’re going to engage with this at all, the two things worth paying for aren’t a number. They’re a verified source and someone qualified actually watching. The most defensible dose is the one a licensed clinician is monitoring. The least defensible is a confident figure copied from a stranger who also can’t verify what was in their own vial.
Questions I hear again and again
Is there a real “standard” Melanotan II dose?
No. There’s no regulator-approved dosing protocol for cosmetic use anywhere, so no figure carries the weight of an approved label or a large safety trial. The microgram numbers traded on forums are user convention, and they earn a “very low” grade on my scorecard because no clinical trial ever validated a loading-then-maintenance schedule for safety or results. The only dosing facts with real human support: low subcutaneous amounts can tan, and pushing the dose pushes the nausea.
The forum numbers sound so precise. Why do they still score low?
Because sounding precise and being accurate are different things. “500 micrograms” describes 500 micrograms of whatever was actually in an unverified research-chemical vial, and those vials carry no guarantee of identity, purity, or peptide content [6]. Reconstitution stacks more error on top, dissolving powder of unknown mass in a self-measured volume, then drawing it up by eye. A confident-sounding number is really an estimate built on estimates.
If I just use a lower dose, is it safe?
No, and this is the part that matters most. The most serious risks are tied to mechanism, not dose size. The melanoma signal in case reports is linked to stimulating pigment cells at all [4], and priapism comes from the same melanocortin activity that produces the intended effect [5]. A lower dose can ease nausea, since that scales with dose [2], but it doesn’t design away harms rooted in what the receptor does.
Does skin type change any of this?
Yes, more than any microgram number does. Dermatologists use the Fitzpatrick scale, and the fair-skinned types who tan poorly are both most drawn to a tanning compound and at higher baseline skin-cancer risk per the literature. Copy-paste forum protocols assume one schedule fits everyone, which is exactly why they score so low. A dosing plan that ignores who’s taking it isn’t much of a plan.
What does supervision and dose tracking actually add?
It turns guesswork into a record. A supervised setup puts a physician’s review and a licensed pharmacy ahead of an anonymous vendor, and a dose log turns “eyeball the tan and adjust by feel” into a dated record a clinician can actually check against known warning signs, like a changing mole or shifting blood pressure. It doesn’t make the compound approved or proven. It just means the experience produces information someone qualified can use, instead of disappearing into memory.
What does Melanotan II actually do in the body?
It binds to melanocortin receptors, triggering melanin production and some degree of tanning, usually alongside nausea, facial flushing, spontaneous erections, and appetite suppression. Those receptors sit throughout the body, which is exactly why the effects go well past skin color. No regulatory agency has approved it for any use, and the full receptor picture is still being worked out.
Does it work without any sun exposure?
It can produce some darkening without UV light, but the result tends to be modest and uneven compared to what people report when they combine it with sun or tanning beds. The melanin-stimulating mechanism works independently of UV exposure, but UV appears to amplify it. Combining an unregulated peptide with deliberate UV exposure stacks two separate risks on top of each other, which is worth thinking through rather than shrugging off.
Can it actually change eye color?
There are anecdotal reports of iris darkening, and melanocortin receptors do exist in ocular tissue, so a biological pathway is plausible. Controlled evidence on this specific effect is essentially nonexistent, though. Any pigment or structural change in the eye from an uncharacterized compound deserves a conversation with an ophthalmologist, not a shrug based on forum anecdotes.
Where do people usually get it, and does the source affect dosing?
Most people buy it from research-chemical websites or gray-market peptide suppliers, where purity and concentration are unverified. That makes any dosing figure close to meaningless, since a vial labeled 10 mg could contain more, less, or something else entirely. The source matters enormously here. A physician-supervised compounding route, like FormBlends, at least offers documented compounding standards and clinician accountability, a genuinely different category from an anonymous online seller.
References (primary sources)
- Dorr RT, Lines R, Levine N, Brooks C, Xiang L, Hruby VJ, et al. Evaluation of melanotan-II, a superpotent cyclic melanotropic peptide in a pilot phase-I clinical study. Life Sciences, 1996. PMID 8637402.
- Wessells H, Levine N, Hadley ME, Dorr R, Hruby V. Melanocortin receptor agonists, penile erection, and sexual motivation: human studies with Melanotan II. International Journal of Impotence Research, 2000. PMID 11035391.
- Dorr RT, Ertl G, Levine N, Brooks C, Bangert JL, Powell MB, et al. Effects of a superpotent melanotropic peptide in combination with solar UV radiation on tanning of the skin in human volunteers. Archives of Dermatology, 2004. PMID 15262693.
- Hjuler KF, Lorentzen HF. Melanoma associated with the use of melanotan-II. Dermatology, 2014. PMID 24355990.
- Dreyer BA, Amer T, Fraser M. Melanotan-induced priapism: a hard-earned tan. BMJ Case Reports, 2019. PMID 30796078.
- Habbema L, Halk AB, Neumann M, Bergman W. Risks of unregulated use of alpha-melanocyte-stimulating hormone analogues: a review. International Journal of Dermatology, 2017. PMID 28266027.
